Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析

◆英語タイトル:Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1603
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Medical Care AG & Co KGaA (FME) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. It develops and manufactures a comprehensive range of dialysis machines, systems and disposable products. The company also offers Care Coordination services including pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It conducts its operations through its subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co KGaA Key Recent Developments

Apr 23,2020 Fresenius Medical Care North America names New Chief Medical Officer for Renal Therapies Group
Apr 01,2020 Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.
Feb 19,2020 Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
Nov 06,2019 Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Medical Care AG & Co KGaA – Key Facts
Fresenius Medical Care AG & Co KGaA – Key Employees
Fresenius Medical Care AG & Co KGaA – Key Employee Biographies
Fresenius Medical Care AG & Co KGaA – Major Products and Services
Fresenius Medical Care AG & Co KGaA – History
Fresenius Medical Care AG & Co KGaA – Company Statement
Fresenius Medical Care AG & Co KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Medical Care AG & Co KGaA – Business Description
Business Segment: Health Care Products
Overview
Performance
Key Stats
Business Segment: Health Care Services
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Corporate
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Medical Care AG & Co KGaA – Corporate Strategy
Fresenius Medical Care AG & Co KGaA – SWOT Analysis
SWOT Analysis – Overview
Fresenius Medical Care AG & Co KGaA – Strengths
Fresenius Medical Care AG & Co KGaA – Weaknesses
Fresenius Medical Care AG & Co KGaA – Opportunities
Fresenius Medical Care AG & Co KGaA – Threats
Fresenius Medical Care AG & Co KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Fresenius Medical Care North America names New Chief Medical Officer for Renal Therapies Group
Apr 01, 2020: Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.
Feb 19, 2020: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
Nov 06, 2019: Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week
Nov 04, 2019: Fresenius Medical Care North America announces availability of advanced water purification systems for Hemodialysis
Oct 29, 2019: Fresenius Medical Care again delivers strong organic growth in the third quarter
Oct 29, 2019: Fresenius Medical Care appoints Dr. Frank Maddux to management board, makes global chief medical officer a board position
Oct 28, 2019: Fresenius Medical Care celebrates 10th anniversary and expansion of their dialysis center with enhanced home therapy support in Perth, Western Australia
Oct 22, 2019: Donate Life America and the Fresenius Medical Care Foundation announce groundbreaking National, Universal Living Donor Kidney Registry
Oct 17, 2019: More people in Phnom Penh living with kidney disease will have access to dialysis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Medical Care AG & Co KGaA, Key Facts
Fresenius Medical Care AG & Co KGaA, Key Employees
Fresenius Medical Care AG & Co KGaA, Key Employee Biographies
Fresenius Medical Care AG & Co KGaA, Major Products and Services
Fresenius Medical Care AG & Co KGaA, History
Fresenius Medical Care AG & Co KGaA, Subsidiaries
Fresenius Medical Care AG & Co KGaA, Key Competitors
Fresenius Medical Care AG & Co KGaA, Ratios based on current share price
Fresenius Medical Care AG & Co KGaA, Annual Ratios
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...1)
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...2)
Fresenius Medical Care AG & Co KGaA, Interim Ratios
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Fresenius Medical Care AG & Co KGaA, Performance Chart (2015 - 2019)
Fresenius Medical Care AG & Co KGaA, Ratio Charts
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Targovax ASA (TRVX):企業の財務・戦略的SWOT分析
    Summary Targovax ASA (Targovax) is a developer and commercializer of immunotherapies for the treatment of cancer patients. The company’s lead candidates include TG01, a peptide-based therapeutic anti-cancer vaccine under development for pancreatic cancer; and ONCOS-102 is an adenovirus-based pipelin …
  • Bio-Rad Laboratories Inc (BIO):企業の財務・戦略的SWOT分析
    Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sigmatech, Inc.:企業の戦略・SWOT・財務情報
    Sigmatech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sigmatech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Pyxant Labs Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pyxant Labs Inc (Pyxant) is a bioanalytical laboratory that offers laboratory services. The laboratory’s services include picogram-level bioanalytical method development and validation, analytical and bioanalytical support for ADME studies, and analytical and bioanalytical support for pharma …
  • Kane Biotech Inc (KNE):製薬・医療:M&Aディール及び事業提携情報
    Summary Kane Biotech Inc (Kane Biotech) is a developer of pharmaceutical products that prevent and remove microbial biofilms. The company uses patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. It develop …
  • Bellicum Pharmaceuticals Inc (BLCM):企業の財務・戦略的SWOT分析
    Summary Bellicum Pharmaceuticals, Inc. (Bellicum) is a clinical stage biopharmaceutical company, which is engaged in developing cellular immunotherapies for the treatment of cancer. The company develops its product candidates through its chemical induction of dimerization technology platforms in the …
  • MKS Instruments Inc (MKSI):企業の財務・戦略的SWOT分析
    MKS Instruments Inc (MKSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Targa Resources Corp (TRGP):企業の財務・戦略的SWOT分析
    Targa Resources Corp (TRGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Suncorp Group Ltd:企業のM&A・事業提携・投資動向
    Suncorp Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Suncorp Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • BASF Mexicana SA de CV:企業の戦略的SWOT分析
    BASF Mexicana SA de CV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Lyka Labs Ltd (LYKALABS):企業の財務・戦略的SWOT分析
    Summary Lyka Labs Ltd (Lyka Labs) is a manufacturer of pharmaceutical formulations and active pharmaceutical ingredients. The company provides formulations such as lyophilized injections, topical formulations of cream, ointment, foams, gels and lotions. It offers formulation research and development …
  • Emera Inc (EMA):企業の財務・戦略的SWOT分析
    Emera Inc (EMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Safety-Kleen, Inc.:企業の戦略・SWOT・財務情報
    Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Safety-Kleen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Odfjell Drilling Ltd (ODL):企業の財務・戦略的SWOT分析
    Odfjell Drilling Ltd (ODL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • National Bank of Canada:企業のM&A・事業提携・投資動向
    National Bank of Canada - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Bank of Canada Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisition …
  • ZTE Corp:企業の戦略・SWOT・財務情報
    ZTE Corp - Strategy, SWOT and Corporate Finance Report Summary ZTE Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cambrex Corp (CBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Cambrex Corp (Cambrex) is a life science company that focuses on the development and commercialization of small molecule therapeutics. The company’s major products include active pharmaceutical ingredients (APIs), advanced intermediates and drug delivery products for branded and generic phar …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company’s chemical products include intermediates, monomers and petrochemicals. Its performance products …
  • The Advisory Board Company:企業の戦略的SWOT分析
    The Advisory Board Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Neptune Marine Services Ltd (NMS):企業の財務・戦略的SWOT分析
    Summary Neptune Marine Services Ltd (NMSL), a subsidiary of MTQ Corp Ltd, is an engineering solutions provider. The company's services include commercial diving; manufacturing, testing and assembly; dry underwater welding; survey, geophysical and geotechnical services, asset integrity services, ROV …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆